HWM
ANGO icon

HighMark Wealth Management’s AngioDynamics ANGO Stock Holding History

HighMark Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,500
Closed -$50.3K – 592
2025
Q3 		$50.3K Hold
4,500
– – 0.02% 156
2025
Q2 		$44.6K Hold
4,500
– – 0.02% 164
2025
Q1 		$42.3K Hold
4,500
– – 0.03% 137
2024
Q4 		$41.2K Hold
4,500
– – 0.02% 140
2024
Q3 		$35K Hold
4,500
– – 0.02% 163
2024
Q2 		$27.2K Hold
4,500
– – 0.02% 173
2024
Q1 		$26.4K Buy
4,500
+1,500
+50% +$8.91K 0.02% 178
2023
Q4 		$23.5K Hold
3,000
– – 0.02% 178
2023
Q3 		$21.9K Buy
3,000
+700
+30% +$5.82K 0.02% 167
2023
Q2 		$24K Buy
+2,300
New +$22.1K 0.02% 167

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HighMark Wealth Management's ANGO Position: Q4 2025 in Review

HighMark Wealth Management sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 4,500 shares — an estimated $50.3K sold.

HighMark Wealth Management first reported a position in ANGO in Q2 2023 and held it in 10 quarters. The position peaked at $50.3K in Q3 2025. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • HighMark Wealth Management reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • HighMark Wealth Management sold 4,500 AngioDynamics shares in Q4 2025, an estimated $50.3K.
  • HighMark Wealth Management first reported a position in AngioDynamics in Q2 2023 and held it in 10 quarters.
  • HighMark Wealth Management's AngioDynamics position peaked at $50.3K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.